This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James W. Maas, MD; Jan A. Fawcett, MD; Haroutune Dekirmenjian, PhD

Arch Gen Psychiatry. 1972;26(3):252-262.

Abstract
The relationship between therapeutic response and the urinary excretion of norepinephrine and its metabolites by depressed patients before and during treatment with imipramine or desimipramine has been examined. Those patients who excreted the lesser quantities of 3-methoxy-4-hydroxyphenylglycol (MHPG) prior to drug treatment had the best response to medication. Similar relationships were not found for metanephrine, normetanephrine, or vanillymandelic acid (VMA). Those patients who responded best excreted greater quantities of normetanephrine and MHPG during drug treament, relative to the predrug period, and those patients who responded least well had a decrement in the excretion of these two metabolities. There were significant decrements in the quantities of VMA and metanephrine excreted in urine during drug treatment but these changes were unrelated to the therapeutic response. The theoretical and practical implications of these findings are discussed.

Author Affiliations
Chicago

From the Illinois State Psychiatric Institute, Chicago.

Footnotes
Accepted for publication Sept 8, 1971.

A portion of this paper was read before the American Psychiatric Association, Washington, DC, May, 1971.

Reprint requests to Illinois State Psychiatric Institute, 1601 W Taylor St, Chicago 60612 (Dr. Maas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinoid-Mediated Regulation of Mood: Possible Cellular Mechanisms
O'Reilly et al.
Exp. Biol. Med. 2008;233:251-258.
ABSTRACT | FULL TEXT  

Elevated Brain Serotonin Turnover in Patients With Depression: Effect of Genotype and Therapy
Barton et al.
Arch Gen Psychiatry 2008;65:38-46.
ABSTRACT | FULL TEXT  

Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness: Evidence in Support of the Catecholamine Hypothesis of Mood Disorders
Lambert et al.
Arch Gen Psychiatry 2000;57:787-793.
ABSTRACT | FULL TEXT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Dopamine Metabolism and Disposition in Schizophrenic Patients: Studies Using Debrisoquin
Maas et al.
Arch Gen Psychiatry 1988;45:553-559.
ABSTRACT  

High Intercorrelations Among Urinary Outputs of Norepinephrine and Its Major Metabolites: A Replication in Depressed Patients and Controls
Roy et al.
Arch Gen Psychiatry 1988;45:158-161.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Catecholamine Metabolism and Disposition in Healthy and Depressed Subjects
Maas et al.
Arch Gen Psychiatry 1987;44:337-344.
ABSTRACT  

Tricyclic Antidepressant Washout Effects on Cerebrospinal Fluid and Urinary Monoamine and Metabolites
Koslow et al.
Arch Gen Psychiatry 1986;43:1012-1013.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol and Major Affective Disorders: A Replication and New Findings
Muscettola et al.
Arch Gen Psychiatry 1984;41:337-342.
ABSTRACT  

Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid
Becker et al.
Science 1983;221:476-478.
ABSTRACT  

Alteration of Norepinephrine Metabolism With Desipramine and Zimelidine in Depressed Patients
Linnoila et al.
Arch Gen Psychiatry 1982;39:1025-1028.
ABSTRACT  

High Correlation of Norepinephrine and Its Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1982;39:521-523.
ABSTRACT  

Antipsychotic Effects of Pimozide in Schizophrenia: Treatment Response Prediction With Acute Dextroamphetamine Response
van Kammen et al.
Arch Gen Psychiatry 1982;39:261-266.
ABSTRACT  

Plasma MHPG in Rapid Cyclers and Healthy Twins
Jimerson et al.
Arch Gen Psychiatry 1981;38:1287-1290.
ABSTRACT  

Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for the Etiology and Therapy of Depression
Charney et al.
Arch Gen Psychiatry 1981;38:1160-1180.
ABSTRACT  

Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG)
Keeton et al.
Science 1981;211:586-588.
ABSTRACT  

Conversion of MHPG to Vanillylmandelic Acid: Implications for the Importance of Urinary MHPG
Blombery et al.
Arch Gen Psychiatry 1980;37:1095-1098.
ABSTRACT  

Subtypes of Depression Based on Excretion of MHPG and Response to Nortriptyline
Hollister et al.
Arch Gen Psychiatry 1980;37:1107-1110.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol Circadian Rhythm: Early Timing (Phase-Advance) in Manic-Depressives Compared With Normal Subjects
Wehr et al.
Arch Gen Psychiatry 1980;37:257-263.
ABSTRACT  

3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo
Maas et al.
Science 1979;205:1025-1027.
ABSTRACT  

Novel Antidepressants and the Biogenic Amine Hypothesis of Depression: The Case for Iprindole and Mianserin
Zis and Goodwin
Arch Gen Psychiatry 1979;36:1097-1107.
ABSTRACT  

Urinary MHPG Levels and Tricyclic Antidepressant Drug Selection: A Preliminary Communication on Improved Drug Selection in Clinical Practice
Cobbin et al.
Arch Gen Psychiatry 1979;36:1111-1115.
ABSTRACT  

State Anxiety, Physical Activity, and Urinary 3-Methoxy-4-Hydroxyphenethylene Glycol Excretion
Sweeney et al.
Arch Gen Psychiatry 1978;35:1418-1423.
ABSTRACT  

Toward a Biochemical Classification of Depressive Disorders: I. Differences in Urinary Excretion of MHPG and Other Catecholamine Metabolites in Clinically Defined Subtypes of Depressions
Schildkraut et al.
Arch Gen Psychiatry 1978;35:1427-1433.
ABSTRACT  

Primary Affective Disorder, Clinical State Change, and MHPG Excretion: A Longitudinal Study
Pickar et al.
Arch Gen Psychiatry 1978;35:1378-1383.
ABSTRACT  

Imipramine and Desipramine in Plasma and Spinal Fluid: Relationship to Clinical Response and Serotonin Metabolism
Muscettola et al.
Arch Gen Psychiatry 1978;35:621-625.
ABSTRACT  

Catecholamine Metabolism in Anorexia Nervosa
Halmi et al.
Arch Gen Psychiatry 1978;35:458-460.
ABSTRACT  

Clinical and Biochemical Heterogeneity of Depressive Disorders
MAAS
ANN INTERN MED 1978;88:556-563.
ABSTRACT  

CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Garfinkel et al.
Arch Gen Psychiatry 1977;34:735-739.
ABSTRACT  

Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive Patients: Studies in Normal, "Reactive" and "Endogenous" Depressive, Schizophrenic, and Chronic Alcoholic Subjects
Langer et al.
Arch Gen Psychiatry 1976;33:1471-1475.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT  

Medical News
JAMA 1976;236:2269-2279.
ABSTRACT  

Electroencephalographic Sleep Diagnosis of Primary Depression
Coble et al.
Arch Gen Psychiatry 1976;33:1124-1127.
ABSTRACT  

Biogenic Amines and Depression: Biochemical and Pharmacological Separation of Two Types of Depression
Maas and Maas
Arch Gen Psychiatry 1975;32:1357-1361.
ABSTRACT  

The Basis for Amine Hypotheses in Affective Disorders: A Critical Evaluation
Baldessarini
Arch Gen Psychiatry 1975;32:1087-1093.
ABSTRACT  

Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame
Akiskal and McKinney
Arch Gen Psychiatry 1975;32:285-305.
ABSTRACT  

Antidepressant Response to Tricyclics and Urinary MHPG in Unipolar Patients: Clinical Response to Imipramine or Amitriptyline
Beckmann and Goodwin
Arch Gen Psychiatry 1975;32:17-21.
ABSTRACT  

Brain Biogenic Amine Depletion and Mood
Mendels and Frazer
Arch Gen Psychiatry 1974;30:447-451.
ABSTRACT  

Norepinephrine Uptake into Cerebral Cortical Synaptosomes after One Fight or Electroconvulsive Shock
Welch et al.
Science 1974;183:220-221.
ABSTRACT  

Behavior of Free-Ranging Macaques after Intraventricular 6-Hydroxydopamine
Redmond et al.
Science 1973;181:1256-1258.
ABSTRACT  

Relation of Exercise to MHPG Excretion in Normal Subjects
Goode et al.
Arch Gen Psychiatry 1973;29:391-396.
ABSTRACT  

MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep
Schildkraut et al.
Science 1973;181:762-764.
ABSTRACT  

Drug Spotlight Program: Uses of Psychotherapeutic Drugs
HOLLISTER
ANN INTERN MED 1973;79:88-98.
ABSTRACT